CXCR3 and Huntington disease: Fifth, there was no statistical difference in the total CD11b+CD14+ monocytes between convalescent COVID-19 and HD (Supplemental Figure 1A), but a specific CXCR3+ CD11b+CD14+ monocyte subset was significantly increased during disease convalescence (Figures 1A–C).